| Home : April 2013 : April 08, 2013 News : scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates |
scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates |
April 08, 2013
BOSTON, April 8, 2013 /PRNewswire/ -- scPharmaceuticals LLC today announced that it has entered into a strategic partnership and product development agreement with Sensile Medical Holding AG of Zug, Switzerland to develop an innovative new therapeutic option for patients with heart...
http://www.prnewswire.com/news-releases/scpharmaceuticals-llc-announces-strategic-partnership-with-sensile-medical-to-develop-novel-heart-failure-treatment-aimed-to-reduce-readmission-rates-201878311.html
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|